Feng Zhou
Fortune : 53 300 $ au 31/07/2026
Fortune : 53 300 $ au 31/07/2026
Feng Zhou currently works at Guoxin Venture Capital Management (Shenzhen) Co. Ltd., as Executive Director from 2017, 3D Medicines, Inc., as Non-Executive Director from 2021, and Shandong Weigao Blood Purification Products Co., Ltd., as Independent Director from 2023.
Mr. Zhou received his graduate degree in 2005 from Fudan University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
3D MEDICINES, INC. 0,07% | 28/07/2026 | 193 500 ( 0,07% ) | 53 300 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| 3D MEDICINES INC. | Directeur/Membre du Conseil | 09/10/2019 |
| SHANDONG WEIGAO BLOOD PURIFICATION PRODUCTS CO., LTD. | Directeur/Membre du Conseil | 11/12/2023 |
Guoxin Venture Capital Management (Shenzhen) Co. Ltd. | Directeur/Membre du Conseil | 01/05/2017 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Fudan University
Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shandong Weigao Blood Purification Products Co., Ltd.
Shandong Weigao Blood Purification Products Co., Ltd. Medical SpecialtiesHealth Technology Manufactures and distributes blood dialysis equipment | Health Technology |
Guoxin Venture Capital Management (Shenzhen) Co. Ltd. | |
3D Medicines, Inc.
3D Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio-pharmaceutical company | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national